Daniel Abdun-Nabi, President & CEO at Emergent BioSolutions Inc. (EBS), sold 8,702 shares at $40.17 ($350K) on 2016-04-18, disclosed to the SEC on 2016-04-20.
Scheduled sale ($350k) by President & CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $40.17 | 2,373 | $95K | 27.3% |
| 2 | $40.17 | 2,749 | $110K | 31.6% |
| 3 | $40.17 | 3,580 | $144K | 41.1% |
| Total | $40.17 avg | 8,702 | $350K | 100% |
| Filing → |
| EBS | SELL | 2018-09-18 | $1.9M | — | Filing → |
| EBS | SELL | 2018-09-06 | $5.5M | — | Filing → |
| EBS | SELL | 2018-06-07 | $823K | — | Filing → |